Current Issue
Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 2
Robert Dream, Managing Director, HDR Company LLC
Scheduling and Optimization of Biomanufacturing Activities in Multi-product Facilities wit...
Megan (Rabideau) Sogard, Senior Manufacturing Scheduler, Takeda (previously Manufacturing ...
Single-Use-Systems: Leachable Study Design for Single-Use Components
Katie McGohan, CMC Program Management: Advanced Therapies Lead, Regeneron (previously Scie...
NanoDSF – A Lean Technology to Test Thermal Stability of Vaccines
Marina Kirkitadze, Founding SVP of Sales, SKILLSCAPER Adjunct Professor, York University (...
Column Packing Protocol for Amsphere A3
JSR Life Sciences
Featured Articles
Navigating Technology Transfer
Successful Wetting for Filter Integrity Testing in Volume-Restricted Systems
Accelerating the Commercialization of Biosimilar Medicines in India
Sartorius Stedim Biotech
Expanding Adoption of Single-Use Systems Drives Need for Wider Range of Sterile Connector Technologies
James Barry, Director of Marketing, Americas, Pall Biotech
View All Featured ArticlesCareers
Delivering Better Outcomes for Patients Starts with Creating a Workplace Where all Colleagues Can Thrive
Ahmed Elhusseiny, Roche Pharmaceuticals, Area Head, Asia Pacific
Amgen is a Company that Cares about People, I Feel Genuinely Listened to Here
Jason Rudd, Amgen, Statistical Programming Manager
Inspiring the Next Generation at Bristol Myers Squibb
Elizabeth Jurica, Bristol Myers Squibb, Principal Scientist
A Great Working Atmosphere, Strong Collegial Relationships, and Opportunities to Grow at Lonza
Vijetha Bhat, Lonza, Houston,Texas, Scientist, Research and Development
At Bayer We Foster an Environment of Openness and Understanding Not Pity
Jürgen Schrapp, Bayer, Head of R&D Procurement
The Best Thing About Evotec, Without Question, Is The People
Stuart Flanagan, Evotec, Group Leader
View All Careers ArticlesHeadline News
Lilly’s Retevmo cut the risk of disease recurrence or death by 83% as adjuvant therapy in people with early stage RET fusion positive lung cancer
US FDA pushes back decision date for SERENA-6 filing of camizestrant to allow review of additional data
TALZENNA and XTANDI combination cuts radiographic disease progression risk by over half in metastatic prostate cancer
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Characterisation of Host-Cell Proteins using Mass Spectrometry Enables Effective Purification Optimisation
Presented by Dr Li Zang of Biogen
31st October 2017
Just in Time Release of CAR T Cell Therapies During Covid-19
Presented by Irving Ford, Site QA Head multi-product CAR T facility at Bristol Myers Squibb and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
29th November 2021
A Versatile Solution for Host Cell Proteins (HCPs) and Aggregates Removal for mAbs Purification
Presented by Catherine Allioux & Gareth Leach, Ph.D
08th June 2017
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere TM A3
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Best Practices for Achieving Virus Safety
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
